Interplay between triglyceride-glucose index, cardiometabolic risk, and premature/early-onset major adverse cardiovascular and cerebrovascular events
The American Journal of the Medical Sciences · 2026-11 · 372 (5) · 372-376
DOI: 10.1016/j.amjms.2026.01.014 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift The American Journal of the Medical Sciences, 2026-11. Verfasst von Lakshmi Sai Meghana Kodali und 8 weiteren Autor:innen. Beteiligte Einrichtung: Public Health & Health Sciences Department, University of Michigan - Flint, Flint, MI, USA. Hauptthemen laut MEDLINE: Triglycerides, Cardiovascular Diseases, Blood Glucose, Cerebrovascular Disorders. Die Arbeit nennt 43 Literaturangaben.
Abstract (Originalsprache)
The increasing prevalence of cardiovascular diseases (CVD) and type 2 diabetes, particularly among younger populations, highlights the urgent need for early, cost-effective risk assessment tools. The Triglyceride-Glucose (TyG) index, derived from routine triglyceride and glucose levels, has emerged as a reliable predictor of insulin resistance and is gaining recognition for its role in forecasting cardiovascular risk, including Major Adverse Cardiac and Cerebrovascular Events (MACCE). Unlike more complex and costly insulin resistance tests, the TyG index offers a simpler approach to early detection, particularly in individuals without obvious clinical signs of metabolic disease. This narrative review synthesizes evidence on the association between the TyG index and various cardiovascular outcomes, focusing on early-onset conditions such as atherosclerotic cardiovascular disease (ASCVD), myocardial infarction (MI), coronary artery disease (CAD), stroke, heart failure, and all-cause mortality. Notably, the TyG index has shown predictive value across diverse patient populations, including those free from diabetes or dyslipidemia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Public Health & Health Sciences Department, University of Michigan - Flint, Flint, MI, USA.
- Stanley Medical College, Chennai, TN, India.
- Kamineni Academy of Medical Sciences and Research Centre, Hyderabad, TG, India.
- M.S Ramaiah Medical College, Bangalore, KA, India.
- Shri. B.M. Patil Medical College, Hospital and Research Centre, BLDE University, Vijayapura, KA, India.
- Mamata Medical College, Khammam, TG, India.
Zitieren
APA
Kodali, L. S. M., Suresh, K. R., Pasnoor, D. S., Dhananjaya, H., Madhavaram, N. J., Makarla, V. A., Mody, S. P., Nunna, K., & Desai, R. (2026). Interplay between triglyceride-glucose index, cardiometabolic risk, and premature/early-onset major adverse cardiovascular and cerebrovascular events. The American Journal of the Medical Sciences, 372(5), 372-376. https://doi.org/10.1016/j.amjms.2026.01.014
Vancouver
Kodali LSM, Suresh KR, Pasnoor DS, Dhananjaya H, Madhavaram NJ, Makarla VA, et al. Interplay between triglyceride-glucose index, cardiometabolic risk, and premature/early-onset major adverse cardiovascular and cerebrovascular events. The American Journal of the Medical Sciences. 2026;372(5):372-376. doi:10.1016/j.amjms.2026.01.014
BibTeX
@article{Kodali2026,
author = {Kodali, Lakshmi Sai Meghana and Suresh, Krishna R and Pasnoor, Diksha Sanjana and Dhananjaya, Hemanth and Madhavaram, Neeharika John and Makarla, Venkata Akhil and Mody, Shefali P and Nunna, Krishidhar and Desai, Rupak},
title = {Interplay between triglyceride-glucose index, cardiometabolic risk, and premature/early-onset major adverse cardiovascular and cerebrovascular events},
journal = {The American Journal of the Medical Sciences},
year = {2026},
volume = {372},
number = {5},
pages = {372--376},
doi = {10.1016/j.amjms.2026.01.014}
}
EUVIMED